Journal article
Randomized controlled trials of new oral anticoagulants for stroke prevention in atrial fibrillation
Abstract
PURPOSE OF REVIEW: The prevalence of atrial fibrillation is increasing because of an aging population. Vitamin K antagonists have been the standard therapy for stroke prevention in atrial fibrillation but are underutilized and often poorly managed because of their inherent limitations. This study critically reviews the recently completed phase 3 randomized controlled trials of new oral anticoagulants (OACs) for stroke prevention in patients …
Authors
Liew A; Eikelboom JW; O’Donnell M
Journal
Current Opinion in Cardiology, Vol. 27, No. 4, pp. 331–339
Publisher
Wolters Kluwer
Publication Date
July 2012
DOI
10.1097/hco.0b013e3283540857
ISSN
0268-4705